+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Peptide Therapeutics Market by Application, Drug Type, Type of Manufacturing, Synthesis Technology, Solid Phase Peptide Synthesis, and Hybrid Technology) and Geography - Global Forecast up to 2026

  • ID: 5446337
  • Report
  • May 2021
  • Region: Global
  • 109 Pages
  • Infoholic Research LLP
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

FEATURED COMPANIES

  • Amgen Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline plc (GSK)
  • Lonza Inc
  • Merck & Co. Inc.
  • Novartis International AG
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The growth of the peptide therapeutics market is majorly ascribed to factors including huge investments in drug discovery and a major focus on peptide therapeutics' R&D activities in the ongoing evolution of drugs associated with oncology, including metabolic disorders, infectious diseases, and diabetes. The other primary factor estimated to propel the market growth in the forecasted period is a robust product pipeline in this domain. On the other hand, the growth restricting factors are lack of chemical and physical stability. The Peptide Therapeutics Market is estimated to grow at the rate of 9.67% CAGR by 2026. Peptides are biological molecules that have a prominent role in crucial biological activities. Several attempts have been made in research and development in the pharmaceutical industry to evolve new peptides to treat several chronic conditions. About 7000 peptides have been identified in recent years, which perform as hormones, neurotransmitters, ion channel ligands, and growth factors to provide various human physiologies.

Peptide Therapeutics Market by Application

  • Metabolic
  • Cardiovascular Disorder
  • Respiratory
  • GIT
  • Anti-infection
  • Pain
  • Dermatology
  • CNS
  • Renal
  • Others

Peptide Therapeutics Market by Drug Type

  • Generic
  • Innovative

Peptide Therapeutics Market by Type of Manufacturing

  • In-house
  • Outsourced

Peptide Therapeutics Market by Synthesis Technology

  • Solid Phase Peptide Synthesis (SPPS)
  • Liquid Phase Peptide Synthesis (LPPS)
  • Hybrid Technology

Peptide Therapeutics Market by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
The cancer segment has held the maximum share in the peptide therapeutics market on the basis of application. Since there is an increasing number of cancer patients, it is eventually increasing the prescription of peptide therapeutics to treat cancer. Moreover, the rising demand for efficient and faster-acting therapeutics further accentuates the growth of the segment.

As per the market by drug type, the innovative peptides segment has a significant share in the peptide therapeutics market. This is due to the high investments by various pharmaceuticals in research and development activities to develop and discover new drugs for the increasing number of chronic diseases worldwide.

Further, the market is based on the type of manufacturing; in this segmentation, the in-house manufacturing segment has a major contribution to the peptide therapeutics market share. Most players are involved in the in-house manufacturing process due to strict regulations and high costs incurred in outsourcing.

According to the synthesis technology, the liquid phase peptide synthesis (LPPS) segment has dominated the peptide therapeutics market share. The dominance is attributed to the swelling demand for pure peptides in the development of effective therapeutics. Moreover, the liquid phase peptide synthesis holds usefulness in the extensive production of peptides for industrial purposes.

In terms of geographical segmentation, North America has a substantial share of the peptide therapeutics market growth. This is due to the growing demand for diagnostics in cancer, cardiovascular and other diseases, and the expanding biotechnology industry contributes to the dominance.

Cancer coupled with cardiovascular diseases is the major cause of death in the developed countries around the world. Traditional cancer treatments lack therapeutic uses because of drug resistance, a dearth of tumor selectivity and solubility, and a requirement to develop new therapeutic agents. Therapeutic peptides are a potential and a new effort to treat various diseases and cancer, which has increased the demand for peptide therapeutics.

The vital players of the peptide therapeutics market are Teva Pharmaceuticals Industries Ltd., Novo Nordisk A/S, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc (GSK), Novartis International AG, Amgen Inc., Pfizer Inc., Merck & Co. Inc., and Lonza Inc.

Hence, peptide therapeutics is having various prominent advantages when compared to proteins and antibodies. Peptide therapeutics is crucially used in cancer treatment due to the adverse effects of radiation and chemotherapy.
  • This research provides prominent shifts in market dynamics and segmentation details of the peptide therapeutics market.
  • Historical, present, and future market analysis is depicted in this report as qualitative and quantitative.
  • This research also provides the assessment of market developments and emerging segments and regional markets of the peptide therapeutics market.
  • Essential strategies, company expansions, mergers, acquisitions, and new product launches of major vendors are included in this research.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline plc (GSK)
  • Lonza Inc
  • Merck & Co. Inc.
  • Novartis International AG
1. Executive Summary

2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends

3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets

4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis

5. Application: Market Size & Analysis
5.1. Overview
5.2. Metabolic
5.3. Cardiovascular Disorder
5.4. Respiratory
5.5. GIT
5.6. Anti-infection
5.7. Pain
5.8. Dermatology
5.9. CNS
5.10. Renal
5.11. Others

6. Drug Type: Market Size & Analysis
6.1. Overview
6.2. Generic
6.3. Innovative

7. Type of Manufacturing: Market Size & Analysis
7.1. Overview
7.2. In-house
7.3. Outsourced

8. Synthesis Technology: Market Size & Analysis
8.1. Overview
8.2. Solid Phase Peptide Synthesis (SPPS)
8.3. Liquid Phase Peptide Synthesis (LPPS)
8.4. Hybrid Technology

9. Geography: Market Size & Analysis
9.1. Overview
9.2. North America
9.3. Europe
9.4. Asia Pacific
9.5. Rest of the World

10. Competitive Landscape
10.1. Competitor Comparison Analysis
10.2. Market Developments
10.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
10.2.2. Product Launches and execution

11. Vendor Profiles
11.1. Teva Pharmaceuticals Industries Ltd.
11.1.1. Overview
11.1.2. Financial Overview
11.1.3. Product Offerings
11.1.4. Developments
11.1.5. Business Strategy
11.2. Novo Nordisk A/S
11.2.1. Overview
11.2.2. Financial Overview
11.2.3. Product Offerings
11.2.4. Developments
11.2.5. Business Strategy
11.3. Eli Lilly and Company
11.3.1. Overview
11.3.2. Financial Overview
11.3.3. Product Offerings
11.3.4. Developments
11.3.5. Business Strategy
11.4. Takeda Pharmaceutical Company Limited
11.4.1. Overview
11.4.2. Financial Overview
11.4.3. Product Offerings
11.4.4. Developments
11.4.5. Business Strategy
11.5. GlaxoSmithKline plc (GSK)
11.5.1. Overview
11.5.2. Financial Overview
11.5.3. Product Offerings
11.5.4. Developments
11.5.5. Business Strategy
11.6. Novartis International AG
11.6.1. Overview
11.6.2. Financial Overview
11.6.3. Product Offerings
11.6.4. Developments
11.6.5. Business Strategy
11.7. Pfizer Inc
11.7.1. Overview
11.7.2. Financial Overview
11.7.3. Product Offerings
11.7.4. Developments
11.7.5. Business Strategy
11.8.
11.8.1. Overview
11.8.2. Financial Overview
11.8.3. Product Offerings
11.8.4. Developments
11.8.5. Business Strategy
11.9. Merck & Co. Inc
11.9.1. Overview
11.9.2. Financial Overview
11.9.3. Product Offerings
11.9.4. Developments
11.9.5. Business Strategy
11.10. Lonza Inc
11.10.1. Overview
11.10.2. Financial Overview
11.10.3. Product Offerings
11.10.4. Developments
11.10.5. Business Strategy

12. Analyst Opinion

13. Annexure
13.1. Report Scope
13.2. Market Definitions
13.3. Research Methodology
13.3.1. Data Collation and In-house Estimation
13.3.2. Market Triangulation
13.3.3. Forecasting
13.4. Report Assumptions
13.5. Declarations
13.6. Stakeholders
13.7. Abbreviations

List of Tables
Table 1. Global Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 2. Global Peptide Therapeutics Market Value for Metabolic, by Geography, 2020-2026 (USD Billion)
Table 3. Global Peptide Therapeutics Market Value for Cardiovascular Disorder, by Geography, 2020-2026 (USD Billion)
Table 4. Global Peptide Therapeutics Market Value for Respiratory, by Geography, 2020-2026 (USD Billion)
Table 5. Global Peptide Therapeutics Market Value for Git, by Geography, 2020-2026 (USD Billion)
Table 6. Global Peptide Therapeutics Market Value for Anti-Infection, by Geography, 2020-2026 (USD Billion)
Table 7. Global Peptide Therapeutics Market Value for Pain, by Geography, 2020-2026 (USD Billion)
Table 8. Global Peptide Therapeutics Market Value for Dermatology, by Geography, 2020-2026 (USD Billion)
Table 9. Global Peptide Therapeutics Market Value for Cns, by Geography, 2020-2026 (USD Billion)
Table 10. Global Peptide Therapeutics Market Value for Renal, by Geography, 2020-2026 (USD Billion)
Table 11. Global Peptide Therapeutics Market Value for Others, by Geography, 2020-2026 (USD Billion)
Table 12. Global Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 13. Global Peptide Therapeutics Market Value for Generic, by Geography, 2020-2026 (USD Billion)
Table 14. Global Peptide Therapeutics Market Value for Innovative, by Geography, 2020-2026 (USD Billion)
Table 15. Global Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 16. Global Peptide Therapeutics Market Value for In-House, 2020-2026 (USD Billion)
Table 17. Global Peptide Therapeutics Market Value for Outsourced, by Geography, 2020-2026 (USD Billion)
Table 18. Global Peptide Therapeutics Market Value, Synthesis Technology, 2020-2026 (USD Billion)
Table 19. Global Peptide Therapeutics Market Value for Solid Phase Peptide Synthesis (Spps), by Geography, 2020-2026 (USD Billion)
Table 20. Global Peptide Therapeutics Market Value for Liquid Phase Peptide Synthesis (Lpps), by Geography, 2020-2026 (USD Billion)
Table 21. Global Peptide Therapeutics Market Value for Hybrid Technology, by Geography, 2020-2026 (USD Billion)
Table 22. North America Peptide Therapeutics Market Value, by Country, 2020-2026 (USD Billion)
Table 23. North America Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 24. North America Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 25. North America Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 26. North America Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 27. U.S Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 28. U.S Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 29. U.S Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 30. U.S Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 31. Canada Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 32. Canada Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 33. Canada Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 34. Canada Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 35. Europe Peptide Therapeutics Market Value, by Country, 2020-2026 (USD Billion)
Table 36. Europe Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 37. Europe Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 38. Europe Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 39. Europe Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 40. Germany Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 41. Germany Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 42. Germany Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 43. Germany Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 44. U.K Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 45. U.K Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 46. U.K Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 47. U.K Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 48. France Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 49. France Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 50. France Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 51. France Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 52. Italy Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 53. Italy Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 54. Italy Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 55. Italy Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 56. Spain Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 57. Spain Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 58. Spain Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 59. Spain Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 60. Roe Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 61. Roe Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 62. Roe Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 63. Roe Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 64. Asia Pacific Peptide Therapeutics Market Value, by Country, 2020-2026 (USD Billion)
Table 65. Asia Pacific Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 66. Asia Pacific Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 67. Asia Pacific Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 68. Asia Pacific Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 69. China Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 70. China Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 71. China Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 72. China Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 73. India Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 74. India Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 75. India Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 76. India Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 77. Japan Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 78. Japan Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 79. Japan Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 80. Japan Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 81. Rest of APAC Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 82. Rest of APAC Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 83. Rest of APAC Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 84. Rest of APAC Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 85. Rest of World Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Table 86. Rest of World Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Table 87. Rest of World Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Table 88. Rest of World Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Table 89. Teva Pharmaceuticals Industries Ltd: Financials
Table 90. Teva Pharmaceuticals Industries Ltd: Product And Services
Table 91. Teva Pharmaceuticals Industries Ltd: Recent Developments
Table 92. Novo Nordisk A/S: Financials
Table 93. Novo Nordisk A/S: Product And Services
Table 94. Novo Nordisk A/S: Recent Developments
Table 95. Eli Lilly And Company: Financials
Table 96. Eli Lilly And Company: Product And Services
Table 97. Eli Lilly And Company: Recent Developments
Table 98. Takeda Pharmaceutical Company Limited: Financials
Table 99. Takeda Pharmaceutical Company Limited: Product And Services
Table 100. Takeda Pharmaceutical Company Limited: Recent Developments
Table 101. Glaxosmithkline Plc (GSK): Financials
Table 102. Glaxosmithkline Plc (GSK): Product And Services
Table 103. Glaxosmithkline Plc (GSK): Recent Developments
Table 104. Novartis International AG: Financials
Table 105. Novartis International AG: Product And Services
Table 106. Novartis International AG: Recent Developments
Table 107. Amgen Inc: Financials
Table 108. Amgen Inc: Product And Services
Table 109. Amgen Inc: Recent Developments
Table 110. Pfizer Inc: Financials
Table 111. Pfizer Inc: Product And Services
Table 112. Pfizer Inc: Recent Developments
Table 113. Merck & Co. Inc: Financials
Table 114. Merck & Co. Inc: Product And Services
Table 115. Merck & Co. Inc: Recent Developments
Table 116. Lonza Inc: Financials
Table 117. Lonza Inc: Product And Services
Table 118. Lonza Inc: Recent Developments

List of Figures
Chart. 1. Global Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 2. Global Peptide Therapeutics Market Value for Metabolic, by Geography, 2020-2026 (USD Billion)
Chart 3. Global Peptide Therapeutics Market Value for Cardiovascular Disorder, by Geography, 2020-2026 (USD Billion)
Chart 4. Global Peptide Therapeutics Market Value for Respiratory, by Geography, 2020-2026 (USD Billion)
Chart 5. Global Peptide Therapeutics Market Value for Git, by Geography, 2020-2026 (USD Billion)
Chart 6. Global Peptide Therapeutics Market Value for Anti-Infection, by Geography, 2020-2026 (USD Billion)
Chart 7. Global Peptide Therapeutics Market Value for Pain, by Geography, 2020-2026 (USD Billion)
Chart 8. Global Peptide Therapeutics Market Value for Dermatology, by Geography, 2020-2026 (USD Billion)
Chart 9. Global Peptide Therapeutics Market Value for Cns, by Geography, 2020-2026 (USD Billion)
Chart 10. Global Peptide Therapeutics Market Value for Renal, by Geography, 2020-2026 (USD Billion)
Chart 11. Global Peptide Therapeutics Market Value for Others, by Geography, 2020-2026 (USD Billion)
Chart 12. Global Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 13. Global Peptide Therapeutics Market Value for Generic, by Geography, 2020-2026 (USD Billion)
Chart 14. Global Peptide Therapeutics Market Value for Innovative, by Geography, 2020-2026 (USD Billion)
Chart 15. Global Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 16. Global Peptide Therapeutics Market Value for In-House, 2020-2026 (USD Billion)
Chart 17. Global Peptide Therapeutics Market Value for Outsourced, by Geography, 2020-2026 (USD Billion)
Chart 18. Global Peptide Therapeutics Market Value, Synthesis Technology, 2020-2026 (USD Billion)
Chart 19. Global Peptide Therapeutics Market Value for Solid Phase Peptide Synthesis (Spps), by Geography, 2020-2026 (USD Billion)
Chart 20. Global Peptide Therapeutics Market Value for Liquid Phase Peptide Synthesis (Lpps), by Geography, 2020-2026 (USD Billion)
Chart 21. Global Peptide Therapeutics Market Value for Hybrid Technology, by Geography, 2020-2026 (USD Billion)
Chart 22. North America Peptide Therapeutics Market Value, by Country, 2020-2026 (USD Billion)
Chart 23. North America Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 24. North America Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 25. North America Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 26. North America Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Chart 27. U.S Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 28. U.S Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 29. U.S Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 30. U.S Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Chart 31. Canada Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 32. Canada Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 33. Canada Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 34. Canada Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Chart 35. Europe Peptide Therapeutics Market Value, by Country, 2020-2026 (USD Billion)
Chart 36. Europe Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 37. Europe Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 38. Europe Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 39. Europe Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Chart 40. Germany Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 41. Germany Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 42. Germany Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 43. Germany Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Chart 44. U.K Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 45. U.K Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 46. U.K Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 47. U.K Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Chart 48. France Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 49. France Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 50. France Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 51. France Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Chart 52. Italy Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 53. Italy Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 54. Italy Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 55. Italy Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Chart 56. Spain Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 57. Spain Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 58. Spain Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 59. Spain Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Chart 60. RoE Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 61. RoE Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 62. RoE Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 63. RoE Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Chart 64. Asia Pacific Peptide Therapeutics Market Value, by Country, 2020-2026 (USD Billion)
Chart 65. Asia Pacific Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 66. Asia Pacific Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 67. Asia Pacific Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 68. Asia Pacific Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Chart 69. China Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 70. China Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 71. China Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 72. China Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Chart 73. India Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 74. India Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 75. India Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 76. India Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Chart 77. Japan Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 78. Japan Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 79. Japan Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 80. Japan Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Chart 81. Rest of APAC Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 82. Rest of APAC Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 83. Rest of APAC Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 84. Rest of APAC Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Chart 85. Rest of World Peptide Therapeutics Market Value, by Application, 2020-2026 (USD Billion)
Chart 86. Rest of World Peptide Therapeutics Market Value, by Drug Type, 2020-2026 (USD Billion)
Chart 87. Rest of World Peptide Therapeutics Market Value, by Type of Manufacturing, 2020-2026 (USD Billion)
Chart 88. Rest of World Peptide Therapeutics Market Value, by Synthesis Technology, 2020-2026 (USD Billion)
Note: Product cover images may vary from those shown
  • Teva Pharmaceuticals Industries Ltd.
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Takeda Pharmaceutical Company Limited
  • GlaxoSmithKline plc (GSK)
  • Novartis International AG
  • Amgen Inc.
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Lonza Inc
Note: Product cover images may vary from those shown
Adroll
adroll